Lisdexamfetamine

A prodrug of the d-isomer of amphetamine, a non-catecholamine sympathomimetic amine with central nervous system (CNS) stimulating activity. Upon… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
OBJECTIVES There is a lack of comparative effectiveness research among attention deficit hyperactivity disorder (ADHD) drugs in… (More)
Is this relevant?
2015
2015
Binge-eating disorder is a common psychiatric disorder affecting ~2% of adults. Binge-eating was initiated in freely-fed, lean… (More)
Is this relevant?
2015
2015
CONTEXT Lisdexamfetamine is a pro-drug stimulant that requires the enzymatic hydrolysis of lysine from dexamphetamine for… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
This study evaluated the efficacy and tolerability of lisdexamfetamine (LDX) in the treatment of bipolar depression. Twenty-five… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
BACKGROUND Amphetamine analogs have been demonstrated to have some efficacy in reducing use in cocaine dependent individuals… (More)
Is this relevant?
2015
2015
Effort-related motivational symptoms, such as anergia, psychomotor retardation, and fatigue, are an important aspect of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Reports of cognitive decline, particularly in the domains of executive functions (EFs), are common among menopausal women. This… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
OBJECTIVE To compare treatment persistence in attention-deficit/hyperactivity disorder (ADHD) of patients initiated on… (More)
Is this relevant?
2013
2013
OBJECTIVES Due to concerns about the safety of stimulants for ADHD, novel assessments of the cardiopulmonary impact of these… (More)
Is this relevant?